| Unadjusted OR & 95%CL | Adjusted OR & 95%CL* | ||||
---|---|---|---|---|---|---|
variables | ESSC | dysplasia | Basal cell hyperplasia | ESSC | dysplasia | Basal cell hyperplasia |
ADP | 1.02(0.98-1.06) | 1.03(0.99-1.07) | 1.01(0.97-1.05) | 1.02(0.97-1.06) | 1.03(0.99-1.07) | 1.01(0.96-1.05) |
oxLDL | 0.92(0.88-0.94) | 0.98(0.94-1.01) | 0.96(0.92-1.00) | 0.94(0.89-0.99) | 0.97(0.93-1.01) | 0.95(0.91-0.99) |
oxLDL-ab | 0.93(0.88-0.97) | 0.98(0.96-1.01) | 1.00(0.98-1.02) | 0.96(0.91-1.00) | 0.98(0.95-1.01) | 1.00(0.98-1.02) |
oxLDL-lgG | 0.94(0.87-1.01) | 1.07(1.01-1.14) | 1.09(1.03-1.16) | 1.03(0.94-1.13) | 1.07(0.99-1.16) | 1.07(0.99-1.15) |
oxLDL-lgM | 1.21(1.10-1.33) | 1.15(1.05-1.27) | 1.11(1.01-1.22) | 1.18(1.06-1.31) | 1.11(1.01-1.23) | 1.08(0.98-1.20) |